Slingshot members are tracking this event:
Janssen's (JNJ) Stelara Approved by European Commission for Adults with Moderately to Severely Active Crohn's Disease
Slingshot Insights Explained
Nov 11, 2016
Don’t see a project related to the catalyst you care about?
Related Keywords Stelara, European Commission, Moderate-to-severely Active, Crohn's Disease, Approval